UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 22, 2013

INTEGRA LIFESCIENCES HOLDINGS CORPORATION
(Exact name of Registrant as specified in its charter)

Delaware
0-26224
51-0317849
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)


311 Enterprise Drive
Plainsboro, NJ 08536
(Address of principal executive offices) (Zip Code)
 
Registrant's telephone number, including area code: (609) 275-0500

Not Applicable
(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ]    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ]    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of Integra LifeSciences Holdings Corporation (the “Company”) was held on May 22, 2013. The final results of the matters submitted to a vote of stockholders at the Annual Meeting are as follows:

Item No. 1: All of the Board of Directors' nominees for director were elected to serve until the Company's 2014 Annual Meeting or until their respective successors are elected and qualified, by the votes set forth below.
 
Nominees
For

Against

Abstain

Broker Non-Vote

 
 
Peter J. Arduini    
24,852,630

719,243

2,756

1,119,869

 
 
Keith Bradley    
23,526,413

2,045,195

3,021

1,119,869

 
 
Richard E. Caruso
24,833,206

738,372

3,052

1,119,868

 
 
Stuart M. Essig
24,796,045

761,412

17,172

1,119,869

 
 
Barbara B. Hill
25,476,362

95,352

2,915

1,119,869

 
 
Lloyd W. Howell, Jr.
25,476,661

94,951

3,017

1,119,869

 
 
Neal Moszkowski
24,147,248

1,423,311

4,071

1,119,868

 
 
Raymond G. Murphy
25,475,274

96,069

3,287

1,119,868

 
 
Christian S. Schade
25,358,387

213,211

3,031

1,119,869

 
 
James M. Sullivan
24,840,737

730,629

3,263

1,119,869

 

            
Item No. 2: The stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the 2013 fiscal year, by the votes set forth below.
        
 
For
 
Against
Abstain
Broker Non-Vote
 
 
26,005,542
 
681,027
7,929
0
 


Item No. 3: The stockholders approved the Company's Performance Incentive Compensation Plan, by the votes set forth below.            
    
 
For
 
Against
Abstain
Broker Non-Vote
 
 
24,613,203
 
956,037
5,390
1,119,868
 


Item No. 4: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers, by the votes set forth below.
    
 
For
 
Against
Abstain
Broker Non-Vote
 
 
22,667,118
 
2,887,309
20,202
1,119,869
 







SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
                    
 
INTEGRA LIFESCIENCES HOLDINGS CORPORATION


Date: May 23, 2013
                                
By:
 /s/ John B. Henneman, III 
 
John B. Henneman, III
 
Title:
Corporate Vice President,
Finance and Administration,
and Chief Financial Officer